Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-<i>Trans</i> Retinoic Acid: A Report by the Gruppo Italiano Malattie Ematologiche dell’Adulto

Abstract

APL patients receiving all-trans retinoic acid in addition to chemotherapy have no increased risk of developing EMD at relapse as compared with those treated with chemotherapy alone.